Blood schizontocidal activity of methylene blue in combination with antimalarials against Plasmodium falciparum
Parasite, 14 2 (2007) 135-140
Published online: 2007-06-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Recent developments in antimalarial drug discovery
Théoneste Umumararungu, Jean Bosco Nkuranga, Gratien Habarurema, et al.Bioorganic & Medicinal Chemistry 88-89 117339 (2023)
https://doi.org/10.1016/j.bmc.2023.117339
The activity of methylene blue against asexual and sexual stages of Plasmodium vivax
Camila Fabbri, Glenda Quaresma Ramos, Djane Clarys Baia-da-Silva, et al.Frontiers in Cellular and Infection Microbiology 13 (2023)
https://doi.org/10.3389/fcimb.2023.1108366
Absence of Association between Methylene Blue Reduced Susceptibility and Polymorphisms in 12 Genes Involved in Antimalarial Drug Resistance in African Plasmodium falciparum
Mathieu Gendrot, Océane Delandre, Marie Robert, Francis Foguim, Nicolas Benoit, Rémy Amalvict, Isabelle Fonta, Joel Mosnier, Marylin Madamet, Bruno Pradines and on GroupPharmaceuticals 14 (4) 351 (2021)
https://doi.org/10.3390/ph14040351
Baseline and multinormal distribution of ex vivo susceptibilities of Plasmodium falciparum to methylene blue in Africa, 2013–18
Bruno Pradines, Sébastien Briolant, Nicolas Benoit, et al.Journal of Antimicrobial Chemotherapy (2020)
https://doi.org/10.1093/jac/dkaa174
How worthwhile is methylene blue as a treatment of malaria?
Olaf Müller, Guangyu Lu, Albrecht Jahn and Frank-Peter MockenhauptExpert Review of Anti-infective Therapy 17 (7) 471 (2019)
https://doi.org/10.1080/14787210.2019.1634545
Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions
Tony K. L. Kiang, Kyle John Wilby and Mary H. H. EnsomDrug Interactions in Infectious Diseases: Antimicrobial Drug Interactions 515 (2018)
https://doi.org/10.1007/978-3-319-72416-4_13
Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium
Henriette Bosson-Vanga, Jean-François Franetich, Valérie Soulard, et al.Malaria Journal 17 (1) (2018)
https://doi.org/10.1186/s12936-018-2300-y
Anti-plasmodial effect of plant extracts from Picrolemma huberi and Picramnia latifolia
Wendy Berthi, Alexa González, Alexandra Rios, et al.Malaria Journal 17 (1) (2018)
https://doi.org/10.1186/s12936-018-2301-x
Efficacy and safety of methylene blue in the treatment of malaria: a systematic review
G. Lu, M. Nagbanshi, N. Goldau, et al.BMC Medicine 16 (1) (2018)
https://doi.org/10.1186/s12916-018-1045-3
Evaluation of methylene blue, pyrimethamine and its combination on anin vitro Neospora caninummodel
LUIZ MIGUEL PEREIRA, ISABEL CRISTINA VIGATO-FERREIRA, GABRIELA DE LUCA, CÁSSIA MARIANA BRONZON DA COSTA and ANA PATRÍCIA YATSUDAParasitology 144 (6) 827 (2017)
https://doi.org/10.1017/S0031182016002584
Ex vivo activity of Proveblue, a methylene blue, against field isolates of Plasmodium falciparum in Dakar, Senegal from 2013–2015
Bécaye Fall, Marylin Madamet, Silman Diawara, et al.International Journal of Antimicrobial Agents 50 (2) 155 (2017)
https://doi.org/10.1016/j.ijantimicag.2017.03.019
Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax
Grennady Wirjanata, Boni F. Sebayang, Ferryanto Chalfein, et al.Antimicrobial Agents and Chemotherapy 59 (10) 6117 (2015)
https://doi.org/10.1128/AAC.00874-15
Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials
Tony K. L. Kiang, Kyle John Wilby and Mary H. H. EnsomClinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials 119 (2015)
https://doi.org/10.1007/978-3-319-10527-7_7
Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model
Jérome Dormoi, Sébastien Briolant, Camille Desgrouas and Bruno PradinesMalaria Journal 12 (1) (2013)
https://doi.org/10.1186/1475-2875-12-127
Quinoline Drug–Heme Interactions and Implications for Antimalarial Cytostatic versus Cytocidal Activities
Alexander P. Gorka, Angel de Dios and Paul D. RoepeJournal of Medicinal Chemistry 56 (13) 5231 (2013)
https://doi.org/10.1021/jm400282d
New antimalarial polyketide endoperoxides from the marine sponge Plakinastrella mamillaris collected at Fiji Islands
Carmen Festa, Simona De Marino, Maria Valeria D’Auria, et al.Tetrahedron 69 (18) 3706 (2013)
https://doi.org/10.1016/j.tet.2013.03.006
Cytostatic versus cytocidal profiling of quinoline drug combinations via modified fixed-ratio isobologram analysis
Alexander P Gorka, Lauren M Jacobs and Paul D RoepeMalaria Journal 12 (1) (2013)
https://doi.org/10.1186/1475-2875-12-332
Proveblue (Methylene Blue) as an Antimalarial Agent: In Vitro Synergy with Dihydroartemisinin and Atorvastatin
Jérôme Dormoi, Aurélie Pascual, Sébastien Briolant, et al.Antimicrobial Agents and Chemotherapy 56 (6) 3467 (2012)
https://doi.org/10.1128/AAC.06073-11
The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine
Giovanny Garavito, Stéphane Bertani, Miguel Quiliano, et al.Memórias do Instituto Oswaldo Cruz 107 (6) 820 (2012)
https://doi.org/10.1590/S0074-02762012000600019
Redox-Active Antiparasitic Drugs
Chinmay Pal and Uday BandyopadhyayAntioxidants & Redox Signaling 17 (4) 555 (2012)
https://doi.org/10.1089/ars.2011.4436
In Vitro Activity of Proveblue (Methylene Blue) on Plasmodium falciparum Strains Resistant to Standard Antimalarial Drugs
Aurélie Pascual, Maud Henry, Sébastien Briolant, et al.Antimicrobial Agents and Chemotherapy 55 (5) 2472 (2011)
https://doi.org/10.1128/AAC.01466-10
Plasmodium falciparum: Solanum nudum SN-1 steroid antiplasmodial activity when combined with antimalarial drugs
Adriana Pabón, Eric Deharo and Silvia BlairExperimental Parasitology 127 (1) 222 (2011)
https://doi.org/10.1016/j.exppara.2010.08.009
Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination
Teun Bousema and Chris DrakeleyClinical Microbiology Reviews 24 (2) 377 (2011)
https://doi.org/10.1128/CMR.00051-10
Glutathione Reductase-null Malaria Parasites Have Normal Blood Stage Growth but Arrest during Development in the Mosquito
Rebecca Pastrana-Mena, Rhoel R. Dinglasan, Blandine Franke-Fayard, et al.Journal of Biological Chemistry 285 (35) 27045 (2010)
https://doi.org/10.1074/jbc.M110.122275
1-Azaaurones derived from the naturally occurring aurones as potential antimalarial drugs
Florence Souard, Sabrina Okombi, Chantal Beney, et al.Bioorganic & Medicinal Chemistry 18 (15) 5724 (2010)
https://doi.org/10.1016/j.bmc.2010.06.008
Antimalarial Activity of Simalikalactone E, a New Quassinoid from Quassia amara L. (Simaroubaceae)
N. Cachet, F. Hoakwie, S. Bertani, et al.Antimicrobial Agents and Chemotherapy 53 (10) 4393 (2009)
https://doi.org/10.1128/AAC.00951-09
Synthesis and Antimalarial Properties of Streptocyanine Dyes
Marie‐Pierre Maether, Denis Desoubzdanne, Albert Izquierdo, Valérie Guieu, Marie Maturano, Christiane André‐Barrès, Alexis Valentin, Valérie Jullian, Séverine Chevalley, Marjorie Maynadier, Henri Vial and Corinne PayrastreChemMedChem 4 (8) 1327 (2009)
https://doi.org/10.1002/cmdc.200900051